Lucent BioSciences
Seed Round in 2021
Lucent Biosciences specializes in the development of innovative biofertilizers aimed at enhancing agricultural sustainability. The company offers a unique class of micronutrient fertilizers that promote higher crop yields and nutrient levels while being environmentally friendly. Their products are designed to improve soil health and sequester carbon, contributing to climate-positive farming practices. By utilizing sustainable bioactive crop nutrition, Lucent Biosciences enables farmers to cultivate nutrient-dense crops without polluting groundwater, thereby supporting regenerative agriculture and reducing overall costs per hectare.
Arbutus Medical
Seed Round in 2020
Arbutus Medical Inc. is a Vancouver-based company that specializes in the development and manufacturing of surgical power tools for orthopedic surgeries. Founded in 2014, the company focuses on creating cost-effective and user-friendly devices, including its flagship orthopedic power tool system, which is designed to be affordable and accessible. Arbutus Medical aims to address the rising costs of healthcare by offering innovative solutions that enhance access to orthopedic surgery for millions of patients, particularly in low- and middle-income countries. Its product portfolio includes various tools and sterile-packed procedure kits, such as the HEX drill kit and PRO drill kit, which are utilized in North American trauma centers, veterinary hospitals, military deployments, and humanitarian missions. Through its commitment to "frugal innovation," Arbutus Medical seeks to improve surgical outcomes while reducing expenses for healthcare providers.
Lucent BioSciences
Seed Round in 2020
Lucent Biosciences specializes in the development of innovative biofertilizers aimed at enhancing agricultural sustainability. The company offers a unique class of micronutrient fertilizers that promote higher crop yields and nutrient levels while being environmentally friendly. Their products are designed to improve soil health and sequester carbon, contributing to climate-positive farming practices. By utilizing sustainable bioactive crop nutrition, Lucent Biosciences enables farmers to cultivate nutrient-dense crops without polluting groundwater, thereby supporting regenerative agriculture and reducing overall costs per hectare.
Alpha9 Theranostics
Seed Round in 2020
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.
Starling Minds
Seed Round in 2019
Starling Minds Inc. is a Vancouver-based company that specializes in digital mental health therapy, focusing on the treatment of stress, burnout, anxiety, and depression. Founded in 2013, it offers an artificial intelligence-powered platform that delivers online Cognitive Behavioral Therapy (CBT) to enhance workplace productivity and mental health. The company provides solutions tailored for businesses, disability management, healthcare, education, insurance providers, and workers' compensation sectors. By utilizing a B2B model, Starling Minds licenses its software-as-a-service technology to employers and healthcare providers, addressing the growing demand for accessible mental health support. Their services aim to guide employees in returning to work successfully and to proactively assist those at risk of mental health challenges, helping to improve overall workplace well-being.
Mesentech
Seed Round in 2019
Mesentech Inc. is a regenerative medicine company based in Vancouver, Canada, focused on developing innovative therapies for bone-related diseases. Established in 2013, the company specializes in a prodrug platform that delivers therapeutics selectively to bone, addressing challenges associated with conventional drug delivery methods. Mesentech's lead product, MES1007, is a bone-targeted prodrug of a prostaglandin mimetic that aims to reverse bone loss associated with conditions such as osteoporosis and Duchenne muscular dystrophy. The company's proprietary technology enhances the delivery of small-molecule and biological drugs to the bone's surface and interior, allowing for more effective treatment while minimizing side effects. This approach is particularly significant given the inherent difficulty in accessing bone tissue due to its hard surface and low porosity. Mesentech's focus on selective drug delivery not only aims to improve treatment efficacy but also hopes to accelerate bone healing and address complications associated with low bone density disorders.
Penny AI Technologies Inc. is a company that develops a customer relationship management application tailored for direct sales businesses. Founded in 2017 and based in Squamish, Canada, Penny employs artificial intelligence and work automation to enhance client support and streamline daily operations for sellers. The platform prioritizes next steps and focuses on improving the customer experience, while also providing tools that enable sellers to manage their activities and organize content effectively. By delivering targeted lists of income-generating activities and automating various processes, Penny allows sales consultants to concentrate on building relationships and increasing revenue, ultimately enabling them to run their businesses with greater confidence and efficiency.
Keycafe
Seed Round in 2019
Keycafe Inc. offers an online platform that enables the remote management of access to homes and rental properties. Established in 2012 and headquartered in Vancouver, Canada, the company provides a combination of software as a service (SaaS) and Internet of Things (IoT) solutions for efficient key exchange and property access management. It caters to both consumers and enterprises, facilitating secure and convenient access for homeowners and rental property managers.
ThisFish
Seed Round in 2018
ThisFish is a company focused on enhancing profitability and sustainability in the seafood industry through advanced digitization and traceability solutions. It specializes in developing seafood traceability and production software that streamlines data entry for workers, simplifies reporting for managers, and delivers high-quality data for executives. By improving process control and compliance within global supply chains, ThisFish aims to bolster the social, environmental, and financial sustainability of seafood production. Founded by Ecotrust Canada, a non-profit organization in Vancouver, ThisFish is recognized as a global leader in its field, dedicated to fostering responsible harvesting and handling of seafood while increasing productivity and efficiency in seafood processing facilities.
Starling Minds
Seed Round in 2018
Starling Minds Inc. is a Vancouver-based company that specializes in digital mental health therapy, focusing on the treatment of stress, burnout, anxiety, and depression. Founded in 2013, it offers an artificial intelligence-powered platform that delivers online Cognitive Behavioral Therapy (CBT) to enhance workplace productivity and mental health. The company provides solutions tailored for businesses, disability management, healthcare, education, insurance providers, and workers' compensation sectors. By utilizing a B2B model, Starling Minds licenses its software-as-a-service technology to employers and healthcare providers, addressing the growing demand for accessible mental health support. Their services aim to guide employees in returning to work successfully and to proactively assist those at risk of mental health challenges, helping to improve overall workplace well-being.
CryoLogistics
Seed Round in 2018
CryoLogistics Refrigeration Technologies is a British Columbia-based manufacturer specializing in clean-tech cold chain equipment. The company has developed an innovative shipping container designed for the transportation of high-value, temperature-sensitive food and pharmaceutical products. This modular, liquid-cooled container utilizes carbon dioxide for refrigeration, offering a rugged and thin-walled solution that significantly enhances capacity within the refrigerated supply chain. By delivering rapid, reliable, and efficient cooling, CryoLogistics' containers enable shippers to reduce transportation costs, accelerate delivery times, and expand their customer base, all while minimizing total emissions.
Wantering
Seed Round in 2012
Wantering operates an online fashion discovery platform designed to help users find and purchase clothing from various sources. The platform aggregates content from fashion blogs and social networks, presenting users with a curated selection of interesting fashion products available across boutiques, flash sales sites, and major retailers. Based in Vancouver, Canada, Wantering streamlines the shopping experience by consolidating multiple retail options into one accessible location.
LightIntegra Technology
Seed Round in 2009
LightIntegra Technology Inc., established in 2009 and headquartered in Vancouver, Canada, is a privately-funded medical diagnostics company specializing in innovative in-vitro diagnostic tests. The company's flagship product, ThromboLUX, is designed to provide healthcare professionals with qualitative and quantitative information about microparticle content in platelet samples. LightIntegra offers the ThromboLUX test kit, control kit, and ThromboSight, a software tool for analyzing test results. Founded by Dr. Elisabeth Maurer, a research scientist from Canadian Blood Services R&D labs, the company aims to minimize platelet refractoriness through its products.
General Fusion
Seed Round in 2007
General Fusion Inc., established in 2002 and headquartered in Burnaby, Canada, specializes in developing commercial Magnetized Target Fusion (MTF), a hybrid fusion method combining magnetic confinement and inertial confinement principles. The company focuses on creating utility-scale fusion power using its patent-pending MTF concept, which has the potential to provide clean, safe, and economical energy. General Fusion develops key subsystems such as plasma injectors, acoustic drivers, and liquid metal vortex compression tests to advance its MTF technology. Backed by a global syndicate of investors, industry leaders, and technology pioneers, General Fusion aims to demonstrate and commercialize its innovative fusion power plants by the end of the decade.
Bionic Power
Seed Round in 2007
Bionic Power is a privately-held technology company based in Vancouver, British Columbia, specializing in wearable technology aimed at enhancing personal mobility. The company focuses on developing its PowerWalk® Kinetic Energy Harvester, primarily for the U.S. military, which allows users to charge batteries through kinetic energy. In addition to this, Bionic Power designs lower-body smart orthoses that improve the quality of life for individuals with mobility challenges. These orthoses enhance knee motion during walking, rebuild weakened muscles, and overall improve walking efficiency, thereby reducing fatigue and increasing mobility for users.
MailChannels
Seed Round in 2007
MailChannels Corporation specializes in email filtering and delivery solutions aimed at addressing IP blacklisting and spam challenges. Founded in 2004 and headquartered in Vancouver, Canada, the company offers products such as MailChannels Cloud, an email relay service that enhances email reputation and delivery reliability by identifying spammers within a network, and MailChannels Dedicated, a robust software solution designed to block spam from reaching the Internet. Catering primarily to shared hosting, dedicated hosting, VPS hosting, cloud hosting, and Internet service providers, MailChannels helps clients like Enom, Arvixe, SendGrid, SherWeb, and Hostwinds improve customer satisfaction and secure their outbound email traffic.
Zymeworks
Seed Round in 2005
Zymeworks Inc. is a clinical-stage biopharmaceutical company based in Vancouver, Canada, focused on the discovery, development, and commercialization of innovative biotherapeutics for cancer treatment. The company's lead candidates include ZW25, a bispecific antibody undergoing Phase I and II clinical trials for various tumors, including biliary tract and gastroesophageal adenocarcinomas, and ZW49, a bispecific antibody-drug conjugate in Phase I trials for advanced HER2-expressing cancers. Zymeworks employs a computational biotechnology approach, utilizing proprietary molecular modeling and simulation technologies to optimize therapeutic antibodies and other protein-based therapeutics. The company has established strategic partnerships with notable organizations such as Merck, Eli Lilly, and Bristol-Myers Squibb, as well as collaborations aimed at advancing antibody discovery and development. Founded in 2003, Zymeworks is dedicated to addressing unmet medical needs through its advanced therapeutic platforms and integrated drug development capabilities.
Aprio Inc. is a software development company based in Vancouver, Canada, that specializes in board portal solutions aimed at enhancing governance for organizations of all sizes. Founded in 2003, Aprio's platform streamlines the management of board meetings by facilitating automated agenda creation, document sharing, and secure collaboration among directors. It provides tools for administrators to easily manage board member roles and track board activity, thereby promoting efficient decision-making and transparent communication. Aprio's software is utilized by a diverse clientele, including financial institutions, non-profits, public companies, and crown corporations across North America, and is recognized for delivering exceptional customer experience in the governance technology sector.